• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨Paget病中I型胶原α1链C末端端肽的β-异构化减少。

Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.

作者信息

Garnero P, Fledelius C, Gineyts E, Serre C M, Vignot E, Delmas P D

机构信息

INSERM Unit 403, Hôpital E. Herriot, Lyon, France.

出版信息

J Bone Miner Res. 1997 Sep;12(9):1407-15. doi: 10.1359/jbmr.1997.12.9.1407.

DOI:10.1359/jbmr.1997.12.9.1407
PMID:9286756
Abstract

In Paget's disease of bone, the normal lamellar bone is replaced by a woven structure with an irregular arrangement of collagen fibers. In this study, we investigated whether the degree of beta-isomerization within C-telopeptide of alpha 1 chain of type I collagen was altered in Paget's disease compared with other bone diseases with no alteration of bone structure. In Paget's disease (n = 26), but not in patients with primary hyperparathyroidism (n = 6) or hyperthyroidism (n = 17), the urinary excretion of nonisomerized (alpha) fragments derived from degradation of type I collagen C-telopeptide (CTX) was markedly increased compared with beta-isomerized CTX (+ 13-fold vs. + 3.5-fold over controls) resulting in an urinary alpha CTX/beta CTX ratio 3-fold higher than in controls (2.6 +/- 1.0 vs. 0.8 +/- 0.3, p < 0.001). In five pagetic patients in complete remission, as demonstrated by normal total alkaline phosphatase activity, the alpha CTX/beta CTX ratio was normal. The immunohistochemistry of normal and pagetic human bone sections showed a preferential distribution of alpha CTX within woven structure, while lamellar bone was intensely stained with an anti-beta CTX antibody, suggesting a lower degree of beta-isomerization of type I collagen in the woven pagetic bone. In collagenase digest of human bone specimens, we found a lower proportion of beta-isomerized type I collagen molecules in pagetic bone (40% of beta CTX) than in normal bone taken from trabecular (68%) and cortical compartments (71%). In conclusion, we found that in Paget's disease the alpha CTX/beta CTX ratio in bone and in urine is markedly increased. This altered beta isomerization can be accurately detected in vivo by measuring urinary degradation products arising from bone resorption.

摘要

在骨佩吉特病中,正常的板层骨被具有不规则排列胶原纤维的编织结构所取代。在本研究中,我们调查了与骨结构无改变的其他骨病相比,佩吉特病中I型胶原α1链C末端肽内β-异构化程度是否发生改变。在佩吉特病患者(n = 26)中,而非原发性甲状旁腺功能亢进患者(n = 6)或甲状腺功能亢进患者(n = 17)中,与β-异构化的I型胶原C末端肽(CTX)相比,源自I型胶原C末端肽(CTX)降解的非异构化(α)片段的尿排泄量显著增加(与对照组相比分别增加13倍和3.5倍),导致尿α CTX/β CTX比值比对照组高3倍(2.6±1.0 vs. 0.8±0.3,p < 0.001)。在5例完全缓解的佩吉特病患者中,总碱性磷酸酶活性正常,α CTX/β CTX比值正常。正常和佩吉特病患者骨切片的免疫组织化学显示,α CTX在编织结构中呈优先分布,而板层骨被抗β CTX抗体强烈染色,提示佩吉特病编织骨中I型胶原的β-异构化程度较低。在人骨标本的胶原酶消化物中,我们发现佩吉特病骨中β-异构化的I型胶原分子比例(β CTX的40%)低于取自小梁(68%)和皮质区(71%)的正常骨。总之,我们发现佩吉特病中骨和尿中的α CTX/β CTX比值显著增加。通过测量骨吸收产生的尿降解产物,可以在体内准确检测到这种改变的β异构化。

相似文献

1
Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.骨Paget病中I型胶原α1链C末端端肽的β-异构化减少。
J Bone Miner Res. 1997 Sep;12(9):1407-15. doi: 10.1359/jbmr.1997.12.9.1407.
2
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.测量I型胶原降解产物的非异构化和β-异构化形式的尿排泄量,以监测双膦酸盐唑来膦酸在佩吉特病中的作用。
Arthritis Rheum. 1998 Feb;41(2):354-60. doi: 10.1002/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5.
3
Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.非异构化C-端肽片段是监测骨Paget病疾病活动和治疗效果的高度敏感标志物。
J Bone Miner Res. 2005 Apr;20(4):588-95. doi: 10.1359/JBMR.041212. Epub 2004 Dec 6.
4
Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.手术绝经和骨佩吉特病对I型胶原羧基末端肽异构化的影响:抗吸收治疗后的演变
J Bone Miner Metab. 2002;20(2):116-20. doi: 10.1007/s007740200016.
5
Investigation of bone disease using isomerized and racemized fragments of type I collagen.使用I型胶原蛋白的异构化和外消旋化片段对骨疾病进行研究。
Calcif Tissue Int. 2003 Jan;72(1):8-17. doi: 10.1007/s00223-002-2034-1. Epub 2002 Oct 21.
6
Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.I型胶原蛋白的消旋化和异构化与绝经后女性骨折风险:OFELY前瞻性研究
J Bone Miner Res. 2002 May;17(5):826-33. doi: 10.1359/jbmr.2002.17.5.826.
7
Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.源自骨吸收的尿液中的胶原蛋白片段高度消旋化和异构化:具有临床潜力的蛋白质老化生物钟。
Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):473-80.
8
Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.骨转换生化标志物在评估佩吉特病活动度中的鉴别价值。
J Bone Miner Res. 1995 Mar;10(3):458-65. doi: 10.1002/jbmr.5650100318.
9
Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.成人成骨不全症中的骨转换和I型胶原C末端肽异构化:与胶原基因突变的关联
Bone. 2009 Mar;44(3):461-6. doi: 10.1016/j.bone.2008.11.006. Epub 2008 Nov 21.
10
Biochemical markers of bone turnover in Paget's disease of bone.骨Paget病中骨转换的生化标志物。
J Bone Miner Res. 1999 Oct;14 Suppl 2:66-9. doi: 10.1002/jbmr.5650140213.

引用本文的文献

1
Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis.交叉路径:揭开癌症骨转移的复杂历程
Biomedicines. 2024 May 13;12(5):1075. doi: 10.3390/biomedicines12051075.
2
Paget's Disease of the Bone and Lynch Syndrome: An Exceptional Finding.骨佩吉特病与林奇综合征:一项特殊发现。
Diagnostics (Basel). 2023 Jun 17;13(12):2101. doi: 10.3390/diagnostics13122101.
3
Bone Turnover Markers: Basic Biology to Clinical Applications.骨转换标志物:基础生物学与临床应用。
Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031.
4
Osteosarcoma mechanobiology and therapeutic targets.骨肉瘤的力学生物学和治疗靶点。
Br J Pharmacol. 2022 Jan;179(2):201-217. doi: 10.1111/bph.15713. Epub 2021 Dec 21.
5
Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.日本老年居民基本注册处随机抽样队列研究中骨代谢的参考值。
Sci Rep. 2021 Apr 9;11(1):7822. doi: 10.1038/s41598-021-87393-7.
6
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.CTX-I 和 PINP 作为骨转换标志物的应用:国家骨健康联盟建议规范样本处理和患者准备,以减少分析前的变异性。
Osteoporos Int. 2017 Sep;28(9):2541-2556. doi: 10.1007/s00198-017-4082-4. Epub 2017 Jun 19.
7
Bone turnover markers: Emerging tool in the management of osteoporosis.骨转换标志物:骨质疏松症管理中的新兴工具。
Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):846-852. doi: 10.4103/2230-8210.192914.
8
The contribution of collagen crosslinks to bone strength.胶原蛋白交联对骨强度的作用。
Bonekey Rep. 2012 Sep 19;1:182. doi: 10.1038/bonekey.2012.182.
9
Bone turnover markers: use in osteoporosis.骨转换标志物:在骨质疏松症中的应用。
Nat Rev Rheumatol. 2012 Jun 5;8(7):379-89. doi: 10.1038/nrrheum.2012.86.
10
Post-translational aging of proteins in osteoarthritic cartilage and synovial fluid as measured by isomerized aspartate.通过异构天冬氨酸测量骨关节炎软骨和滑液中蛋白质的翻译后老化
Arthritis Res Ther. 2009;11(2):R55. doi: 10.1186/ar2675. Epub 2009 Apr 16.